 |
|
| PHOSPHODIESTERASE INHIBITORS
| |
| | |
|
|
To order this title, and for more information, click here
Clive Page, King's College London, U.K.
Christian Schudt, Byk Gulden Pharmaceuticals, Konstan, Germany
Gordon Dent, Kraankenhaus Grobhansdorf, Zentrum fur Pneumologie und Thoraxchirurgie, Grobhansdorf, Germany
Klaus Rabe, Kraankenhaus Grobhansdorf, Zentrum fur Pneumologie und Thoraxchirurgie, Grobhansdorf, Germany
Included in series
Handbook of Immunopharmacology,
Description
Non-selective inhibitors of cyclic nucleotide phosphodiesterase (PDE), such as theophylline, have been used extensively since 1958. In
the decade of the '70s, various PDE isoenzymes were defined which led to the development of the second generation of PDE inhibitors.
Currently a variety of these new inhibitors are under test as potential anti-inflammatory drugs. During the past five years, molecular
biology has revealed a superfamily of these phosphodiesterase isoenzymes. This book summarizes the present state of knowledge, as well
as giving a comprehensive description of the compounds available. It will be invaluable for everyone who wants to choose the most suitable
PDE inhibitor for their research or who is dealing with such drugs in a clinical setting.
Audience
Research level pharmacologists, immunologists, and cell biologists; as a reference text in this area for those involved in degree-level teaching. Pharmaceutical companies.
Contents
K.M. Ferguson and K. Loughney, Identification and Quantification of PDE Isoenzymes and Subtypes by Molecular Biological Methods.
H. Tenor and C. Schudt, Analysis of PDE Isoenzyme Profiles in Cells and Tissues by Pharmacological Methods.K.F. Rabe,
Effects of Theophylline and Nonselective Xanthine Derivatives on PDE Isoenzymes and Cellular Function.R.K. Sharma, Interaction
of PDE I Inhibitors with Isoenzymes and Cell Functions.R. Fischmeister, EHNA as an Inhibitor of PDE II.V.C. Manganiello,
PDE II Inhibitors as Therapeutic Agents.M.A. Giembycz, Interaction of PDE IV Inhibitors with Enzymes and Cell Functions and
their Therapeutic Potential.P.J. Silver, Inhibition of PDE Isoenzymes and Cell Function by Selective PDE V Inhibitors.J.D.
Corbin, Design and Synthesis of Xanthines and Cyclic GMP Analogues as Potent Inhibitors of PDE V and PDE I.A. Hatzelmann,
Enzymatic and Functional Inhibition of Dual-Selective Inhibitors.R. Alvarez, Subtype Selectivity, Inhibition of Cell Function
and Therapeutic Potential of RS 25344.J.E. Souness, Characterization of Different States of PDE IV by Rolipram and RP 73401.
T.J. Torphy, Functional Significance of Two Sites for Inhibitors at PDE IV.
Subject Index.
| Bibliographic details |
Hardbound, 228 pages, publication date: AUG-1996
ISBN-13: 978-0-12-210720-7
ISBN-10: 0-12-210720-9
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
GBP 97
USD 160
EUR 132
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/951
Last update: 12 Jun 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Websites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company